# ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and Adults

> **NCT02529904** · PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 120 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** MF59 - ATIV

## Key facts

- **NCT ID:** NCT02529904
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-12-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02529904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02529904, "ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02529904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*